Delivery Order SPE2DB22D2103-SPE2DB25FR8KV
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$132K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for diabetes management. The contract has a firm fixed price of $35,769.87 and a completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $26,258.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Ozempic, a diabetes medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $70,358.64 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024, with a completion date of August 19, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,647.20 Firm Fixed Price Delivery Order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic, a medication used for diabetes management, to the Defense Logistics Agency (DLA) Troop Support Medical. The $34,921.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024 with a completion date of October 18, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,062.97. This award is a part of AmerisourceBergen's larger Indefinite Delivery...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 22, 2024, with a ceiling value of $1,084.03 and a completion date of November 25, 2024. This is a delivery order contract, with a firm fixed price pricing type. The contract is not designated with a set-aside...
The federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.08, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $3,002.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 20, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication for diabetes management. The contract, valued at $3,553.25, is a firm fixed-price delivery order with a completion date of November 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...